Prevention of cathetersepsis
Conditions
Interventions
Group 1: Application of a new preventive measure during insertion of a central venous catheter
Group 2: Control: Insertion of a central venous catheter without an additional preventive measure
Sponsors
Solvamed GmbH
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: All patients should be included in the study, which: - be supplied with uncoated central venous catheters - have at least a catheter time of 60 hours - have been given their consent and have understood the consent form - are over 18 years old
Exclusion criteria
Exclusion criteria: Patients will not be admitted to the clinical trial if any of the following criteria are available: - Catheter lying time less than 60 hours - in front of lying the catheter, there are already positive blood culture evidence on the side of the clinic - The absence of a signed declaration of consent - Pregnant or breastfeeding women - Patients after catheter change
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction of the number of biofilm positive peaks by at least 25% | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement of the infectious aspects of the patient and the granting of the safety of the product | — |
Countries
Germany
Contacts
Public ContactStefan Margraf
Solvamed GmbH
Outcome results
None listed